ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

E

Elpiscience at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Elpiscience brings 2 presentations to ACR Convergence 2026 in Orlando. Its program centres on antibody and fusion-protein designs aimed at TL1A, including a TL1A and IL23 bispecific for inflammatory bowel disease and a TL1A and LIGHT dual-targeting protein.

OrganizationACR Convergence 2026 Attendance
E
Elpiscience
Biotech companies
A biopharmaceutical company developing antibody-based medicines.

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Elpiscience

Tell us what you sell and we’ll find the people at Elpiscience most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction